openPR Logo
Press release

Enhancement in Molecular Separation Technology to Drive Albumin Market to US$828.2 mn by 2020 at of 2.30% CAGR

06-19-2017 04:15 PM CET | Health & Medicine

Press release from: TMR - Research Reports

Enhancement in Molecular Separation Technology to Drive

Global Albumin Market: Snapshot

Albumin has found wide applications as a robust pharmaceutical excipient in the stabilization of protein therapeutics. It is used as a drug carrier for microparticles and nanoparticles for sustained-release of injectable drugs. Albumin is also widely used in cell culture media as a supplement to bring about growth and productivity of cells and promote overall cell health. The extraordinary properties of albumin helps facilitate stabilization of drugs by lowering oxidation, aggregation, and surface absorption. It also lessens denaturation of the active ingredient that can result from the preparation of a low-dilution solution of the active ingredient.

Read the Upcoming Trends and Global Analysis for Albumin Market at: http://www.transparencymarketresearch.com/albumin-market.html

Albumin has enjoyed considerable demand globally because of the higher stability of products having albumin as an excipient. Additionally, the improvement in molecular separation and protein purification technologies, coupled with rising popularity of recombinant albumin, is predicted to further fillip the global market for albumin in the near future. Countering the growth in the market is the stringent norms pertaining to the use of albumin and its high cost. Concerns over albumin’s effect on the human health is another factor deterring its uptake. Going forward, the increasing demand for customized, serum-free, and chemically defined media will also likely hamper the global albumin market.

On account of considerable constraints, the global market for albumin is predicted to expand at a lackluster pace to attain a value of US$828.2 mn by 2020.

Concerns about Cruelty to Animals Helps Stimulate Demand for Human Serum Albumin

The global market for albumin can be segmented on the basis of application, type, and regions. Depending upon type, the key segments of the market are human serum albumin, bovine serum albumin, and recombinant albumin markets. Among them, the human serum albumin leads the overall market by grossing maximum revenue. In the years ahead, the market segment is expected to hold on to its dominant position to become worth US$557 mn by 2020. Its popularity has stemmed from the growing ethical concerns surrounding bovine serums which are extracted from bovine fetuses rather cruelly and also on account of the fact that some amount of impurities is still retained in the albumin excipient. While the human serum albumin segment holds a leading market share, the recombinant albumin segment is slated to see maximum growth in the upcoming years.

Robust Pharmaceutical Industry Makes North America Dominant Market

Based on geography, the global market for albumin can be segmented into Europe, North America, Asia Pacific, and the Rest of the World. North America, among them, dominates the market, powered largely by the U.S. Reasons for North America’s market leading position is the presence of a robust pharmaceutical industry – one of the primary end users of albumin – in the continent.

Europe and Asia Pacific, which trail North America also contribute considerably to the global albumin market. China is a major market for albumin in the Asia Pacific region. Technological progress in formulation and delivery of drugs and enhanced access to technologies for the use of albumin in culture media present an opportunity to investors in developing economies, particularly in Asia Pacific. A rising number of manufacturers attempting to tap into the developing markets, the growing trend of contract research manufacturing, and the awareness in end-users about albumin as an excipient is predicted to stimulate market growth in the developing economies of Asia Pacific.

Request a sample of this report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=3984

Overall, the global market for albumin is consolidated with a handful of manufacturers that are always on the lookout for a strategic acquisition or partnership to bolster their position.

Transparency Market Research (TMR) is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Enhancement in Molecular Separation Technology to Drive Albumin Market to US$828.2 mn by 2020 at of 2.30% CAGR here

News-ID: 585682 • Views:

More Releases from TMR - Research Reports

Pulmonary Drugs Market is Expected to Reach US$ 28,082.1 Million by the End of 2024
Pulmonary Drugs Market is Expected to Reach US$ 28,082.1 Million by the End of 2 …
According to the research report, the global pulmonary drugs market is expected to be worth US$ 28,082.1 mn by the end of 2024 as compared to US$ 48,039.7 mn in 2015. Analysts calculate that the global market will plummet at a CAGR of -6.3% during the forecast period of 2016 and 2024. The market will thrive as the demand for combination drugs is anticipated to remain on the rise during
North America Ventricular Assist Device Market is rising to a valuation of US$ 1.07 Billion by 2024
North America Ventricular Assist Device Market is rising to a valuation of US$ 1 …
According to TMR, the opportunity in the North America market for VADs, which stood at US$0.4 bn in 2015, is likely to expand at a healthy CAGR of 9.20% between 2016 and 2024 and increase to US$1.07 bn by the end of the forecast period. The destination therapy (DT) segment has been reporting a greater application of VADs than the other two indication segments. It is expected to remain the
Dental Membrane and Bone Graft Substitutes Market to rise to US$ 922.6 Million by 2024
Dental Membrane and Bone Graft Substitutes Market to rise to US$ 922.6 Million b …
Transparency Market Research notes that innovation and expansion into emerging regions have served these companies well in strengthening their hold in the dental membrane and bone graft substitutes market. For instance, Switzerland-based Geistlich Pharma AG - a global manufacturer and supplier of dental products and devices - expanded its operations in Sydney, Australia and New Delhi, India in 2016. The global dental membrane and bone graft substitutes market is expected to
Human Vaccines Market is Estimated to Reach US$ 72.5 Billion by 2024
Human Vaccines Market is Estimated to Reach US$ 72.5 Billion by 2024
The global human vaccines market was valued at US$28.3 bn in 2015 and is estimated to reach US$72.5 bn by 2024, registering an 11.2% CAGR during the forecast period. By age group, pediatric vaccines accounted for a 57.5% share in the global human vaccines market in 2015. Adult vaccines, on the other hand, are expected to expand at a 13.2% CAGR from 2016 to 2024. Based on product, the pneumococcal segment

All 5 Releases


More Releases for Albumin

Albumin Market: Therapeutic Action of Albumin on Liver Function and Blood Circul …
The use of albumin to treat multiple types of deficiencies, including those related to blood volume, is giving an impetus to market growth. It is a high-utility, human-derived protein that has applications across a spectrum of medical operations. Conditions such as hypoalbuminemia, caused by severe injuries, and rapid protein loss due to third-degree burns can be effectively managed through intravenous administration of albumin. Furthermore, albumin administration is the last resort
Albumin Market Geographical Segmentation, Competitive Analysis, Latest Rising Tr …
This intelligence report provides a comprehensive analysis of the Albumin Market. This includes investigating past progress, ongoing market scenarios, and future prospects. Accurate data on the products, strategies and market share of leading companies in this particular market are mentioned. This report provides a 360-degree overview of the global market's competitive landscape. The report further predicts the size and valuation of the global market during the forecast period. Albumin is a
Glycated Albumin Market
Market players and various research organisations are engaged in developing novel diagnostic tests using glycated albumin in order to meet increasing demand from end-use industries. For instance, in 2016, according to a study published in journal Nephrology Dialysis Transplantation reported that glycated albumin might provide a valuable alternative for predicting mortality in diabetic patients on hemodialysis. Furthermore, leading players in the market are focused on new product launches and its
Albumin Market: Increase in Usage of Albumin as Multifunctional Excipient to Boo …
Transparency Market Research (TMR) has published a new report titled, “Albumin (as Excipient) Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026”. According to the report, the global albumin (as excipient) market was valued at US$ 750 Mn in 2017 and is anticipated to reach US$ 1200 Mn by 2026 at a CAGR of over 5.0% from 2018 to 2026. Grant of regulatory approvals coupled with
Albumin Market: Substantial Use of Human Serum Albumin as Pharmaceutical Excipie …
Albumin Market: Snapshot Prominent companies operating in the global albumin market are focusing on product and service extensions to grow their shares. This is serving to stoke competition in the market. In the near future, the competition is slated to intensify further on account of the savvy players striking partnerships or acquiring distributors to augment sales and expand businesses, globally. At the forefront of driving growth in the global albumin market is
Albumin Market: Substantial Use of Human Serum Albumin as Pharmaceutical Excipie …
Albumin Market: Snapshot Prominent companies operating in the global albumin market are focusing on product and service extensions to grow their shares. This is serving to stoke competition in the market. In the near future, the competition is slated to intensify further on account of the savvy players striking partnerships or acquiring distributors to augment sales and expand businesses, globally. At the forefront of driving growth in the global albumin market is